Related Experiment Video
Updated: Aug 7, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Mechanisms of cycloheximide-induced apoptosis in liver cells
A V Alessenko1, Boikov PYa, G N Filippova
1Institute of Biochemical Physics RAS, Moscow, Russia. aless@center.chph.ras.ru
Abstract:
Cycloheximide in sublethal doses caused apoptosis in liver cells in vivo, inducing c-myc, c-fos, c-jun and p53 genes and accumulation of sphingosine, a toxic product of the sphingomyelin cycle. These data support the hypothesis that continuous synthesis of labile protective proteins is required to restrain apoptosis in liver; sphingosine might be important in mediating cycloheximide-induced apoptosis as an endogenous modulator of protein kinase C activity.
Insights
Sublethal cycloheximide induces liver cell apoptosis by activating key genes and accumulating toxic sphingosine. This suggests protective proteins are vital for preventing liver cell death, with sphingosine potentially modulating protein kinase C.
Area of Science:
- Cell Biology
- Molecular Biology
- Toxicology
Background:
- Apoptosis, or programmed cell death, is a critical cellular process.
- The role of specific genes and metabolic products in regulating apoptosis requires further elucidation.
- Understanding liver cell apoptosis is crucial for addressing various liver diseases.
Purpose of the Study:
- To investigate the effects of sublethal cycloheximide on liver cells in vivo.
- To identify the molecular mechanisms underlying cycloheximide-induced apoptosis.
- To explore the potential role of sphingosine in mediating this apoptotic process.
Main Methods:
- Administration of sublethal doses of cycloheximide to liver cells in vivo.
- Gene expression analysis to detect induction of c-myc, c-fos, c-jun, and p53.
- Measurement of sphingosine accumulation within liver cells.
Main Results:
- Cycloheximide treatment triggered apoptosis in liver cells.
- Key apoptosis-related genes (c-myc, c-fos, c-jun, p53) were induced.
- Significant accumulation of sphingosine, a toxic sphingomyelin cycle product, was observed.
Conclusions:
- Continuous synthesis of labile protective proteins may be necessary to prevent liver apoptosis.
- Sphingosine accumulation could play a role in mediating cycloheximide-induced liver cell apoptosis.
- Sphingosine may act as an endogenous modulator of protein kinase C activity in this context.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Related Concept Videos
Inhibition of Cdk Activity
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy